175 related articles for article (PubMed ID: 27810558)
21. The pharmacology study of a new recombinant human VEGF receptor-fc fusion protein on experimental choroidal neovascularization.
Zhang M; Yu D; Yang C; Xia Q; Li W; Liu B; Li H
Pharm Res; 2009 Jan; 26(1):204-10. PubMed ID: 18854954
[TBL] [Abstract][Full Text] [Related]
22. Relative contribution of VEGF and TNF-alpha in the cynomolgus laser-induced CNV model: comparing the efficacy of bevacizumab, adalimumab, and ESBA105.
Lichtlen P; Lam TT; Nork TM; Streit T; Urech DM
Invest Ophthalmol Vis Sci; 2010 Sep; 51(9):4738-45. PubMed ID: 20393113
[TBL] [Abstract][Full Text] [Related]
23. Neovascularization by Sustained Delivery of G-CSF, EPO and VEGF Using Dextran/PLGA Microspheres.
Liu CD; Tu XF; Chen F
Ann Vasc Surg; 2020 Apr; 64():328-338. PubMed ID: 31634610
[TBL] [Abstract][Full Text] [Related]
24. Inhibition of experimental choroidal neovascularization in mice by anti-VEGFA/VEGFR2 or non-specific siRNA.
Gu L; Chen H; Tuo J; Gao X; Chen L
Exp Eye Res; 2010 Sep; 91(3):433-9. PubMed ID: 20599960
[TBL] [Abstract][Full Text] [Related]
25. Triptolide-nanoliposome-APRPG, a novel sustained-release drug delivery system targeting vascular endothelial cells, enhances the inhibitory effects of triptolide on laser-induced choroidal neovascularization.
Lai K; Li Y; Gong Y; Li L; Huang C; Xu F; Zhong X; Jin C
Biomed Pharmacother; 2020 Nov; 131():110737. PubMed ID: 32932044
[TBL] [Abstract][Full Text] [Related]
26. Simultaneous Release of Aflibercept and Dexamethasone from an Ocular Drug Delivery System.
Rudeen KM; Liu W; Mieler WF; Kang-Mieler JJ
Curr Eye Res; 2022 Jul; 47(7):1034-1042. PubMed ID: 35343355
[TBL] [Abstract][Full Text] [Related]
27. Peroxisome proliferator-activated receptor-gamma ligands inhibit choroidal neovascularization.
Murata T; He S; Hangai M; Ishibashi T; Xi XP; Kim S; Hsueh WA; Ryan SJ; Law RE; Hinton DR
Invest Ophthalmol Vis Sci; 2000 Jul; 41(8):2309-17. PubMed ID: 10892878
[TBL] [Abstract][Full Text] [Related]
28. Inhibition of Hypoxia-Inducible Factor-1α and Vascular Endothelial Growth Factor by Chrysin in a Rat Model of Choroidal Neovascularization.
Song JH; Moon KY; Lee SC; Kim SS
Int J Mol Sci; 2020 Apr; 21(8):. PubMed ID: 32325771
[TBL] [Abstract][Full Text] [Related]
29. Antiangiogenic AAV2 gene therapy with a truncated form of soluble VEGFR-2 reduces the growth of choroidal neovascularization in mice after intravitreal injection.
Puranen J; Koponen S; Nieminen T; Kanerva I; Kokki E; Toivanen P; Urtti A; Ylä-Herttuala S; Ruponen M
Exp Eye Res; 2022 Nov; 224():109237. PubMed ID: 36096189
[TBL] [Abstract][Full Text] [Related]
30. Pharmacology study of a chimeric decoy receptor trap fusion protein on retina neovascularization by dual blockage of VEGF and FGF-2.
Jiang J; Xu K; Wang L; Xin W; Zhao G; Huang M; Li S; Luan X; Fang J
Eur J Pharm Sci; 2018 Aug; 121():251-259. PubMed ID: 29715501
[TBL] [Abstract][Full Text] [Related]
31. Anti-Vascular Endothelial Growth Factor Resistance in Exudative Macular Degeneration and Polypoidal Choroidal Vasculopathy.
Kokame GT; deCarlo TE; Kaneko KN; Omizo JN; Lian R
Ophthalmol Retina; 2019 Sep; 3(9):744-752. PubMed ID: 31511169
[TBL] [Abstract][Full Text] [Related]
32. A novel small molecule ameliorates ocular neovascularisation and synergises with anti-VEGF therapy.
Sulaiman RS; Merrigan S; Quigley J; Qi X; Lee B; Boulton ME; Kennedy B; Seo SY; Corson TW
Sci Rep; 2016 May; 6():25509. PubMed ID: 27148944
[TBL] [Abstract][Full Text] [Related]
33. An anti-PLVAP antibody suppresses laser-induced choroidal neovascularization in monkeys.
Nakagami Y; Hatano E; Chayama Y; Inoue T
Eur J Pharmacol; 2019 Jul; 854():240-246. PubMed ID: 31026444
[TBL] [Abstract][Full Text] [Related]
34. Intravitreal itraconazole inhibits laser-induced choroidal neovascularization in rats.
Bae JH; Hwang AR; Kim CY; Yu HG; Koh HJ; Yang WI; Chang HR; Lee SC
PLoS One; 2017; 12(6):e0180482. PubMed ID: 28666022
[TBL] [Abstract][Full Text] [Related]
35. Recombinant humanized anti-vascular endothelial growth factor monoclonal antibody efficiently suppresses laser-induced choroidal neovascularization in rhesus monkeys.
Ji WW; Yu DA; Yang P; Fang P; Cao YX; Li H; Xie N; Yan SS
Eur J Pharm Sci; 2017 Nov; 109():624-630. PubMed ID: 28916483
[TBL] [Abstract][Full Text] [Related]
36. Co-inhibition of PGF and VEGF blocks their expression in mononuclear phagocytes and limits neovascularization and leakage in the murine retina.
Balser C; Wolf A; Herb M; Langmann T
J Neuroinflammation; 2019 Feb; 16(1):26. PubMed ID: 30732627
[TBL] [Abstract][Full Text] [Related]
37. Anti-vascular endothelial growth factor for neovascular age-related macular degeneration.
Solomon SD; Lindsley K; Vedula SS; Krzystolik MG; Hawkins BS
Cochrane Database Syst Rev; 2019 Mar; 3(3):CD005139. PubMed ID: 30834517
[TBL] [Abstract][Full Text] [Related]
38. Subchoroidal Release of VEGF and bFGF Produces Choroidal Neovascularization in Rabbit.
Wong CG; Taban M; Osann K; Ross-Cisneros FN; Bruice TC; Zahn G; You T
Curr Eye Res; 2017 Feb; 42(2):237-243. PubMed ID: 27749103
[TBL] [Abstract][Full Text] [Related]
39. Inhibition of choroidal neovascularization in a nonhuman primate model by intravitreal administration of an AAV2 vector expressing a novel anti-VEGF molecule.
Lukason M; DuFresne E; Rubin H; Pechan P; Li Q; Kim I; Kiss S; Flaxel C; Collins M; Miller J; Hauswirth W; Maclachlan T; Wadsworth S; Scaria A
Mol Ther; 2011 Feb; 19(2):260-5. PubMed ID: 20978476
[TBL] [Abstract][Full Text] [Related]
40. Treatment Efficacy and Biocompatibility of a Biodegradable Aflibercept-Loaded Microsphere-Hydrogel Drug Delivery System.
Liu W; Tawakol AP; Rudeen KM; Mieler WF; Kang-Mieler JJ
Transl Vis Sci Technol; 2020 Oct; 9(11):13. PubMed ID: 33117605
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
